Andrew Kolodny
Senior Scientist
Profile
Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national
nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical
Center in New York City. Dr. Kolodny has a long-standing interest in public health. He
began his career working for the New York City Department of Health and Mental
Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he
helped develop and implement multiple programs to improve the health of New Yorkers
and save lives, including citywide buprenorphine programs, naloxone overdose
prevention programs and emergency room-based screening, brief intervention and
referral to treatment (SBIRT) programs for drug and alcohol misuse.
Dr. Kolodny's testimony before for the United States Congress is available here.
Senate Caucus on International Narcotics Control. May 14, 2014
America's Addiction to Opioids: Heroin and Prescription Drug Use
Homeland Security and Governmental Affairs. January 17, 2018
Unintended Consequences: Medicaid and the Opioid Epidemic
Committee on Energy & Commerce, Subcommittee on Health, U.S. House of Representatives. February 28, 2018
Combatting the Opioid Crisis
See the listing of Dr. Kolodny's publications on PubMed
here.
Awards and Honors
- University of Chicago Leon I. Goldberg Award (2019)
Scholarship
- Kolodny, Andrew. "Assessment of Excess Mortality Associated With Drug Overdose in Ohio From 2009 to 2018." JAMA Network Open (2021).
- Kolodny, Andrew. "How FDA Failures Contributed to the Opioid Crisis." AMA Journal of Ethics (2021).
- Kolodny, Andrew. "Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age.." JAMA Network Open (2021).
- Kolodny, Andrew. "Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2)." Drug Alcohol Depend 223. 108721 (2021).